论文部分内容阅读
目的:观察序贯疗法治疗儿童社区获得性肺炎的疗效。方法:70例社区获得性肺炎患儿随机分为两组,对照组36例,连续静滴头孢噻肟钠10～14 d,序贯疗法组34例静滴头孢噻肟钠3～5 d,病情稳定后改为头孢克肟颗粒口服治疗5～7 d。结果:对照组及序贯疗法组总有效率分别为86.11%,82.35%(P>0.05);平均费用分别为(1.7±0.4)和(2.3±0.7)千元(P<0.05)。结论:序贯疗法治疗儿童社区获得性肺炎安全、有效,且依从性好,费用低。
Objective: To observe the efficacy of sequential therapy in children with community-acquired pneumonia. Methods: Seventy patients with community-acquired pneumonia were randomly divided into two groups. The control group consisted of 36 patients with continuous infusion of cefotaxime sodium for 10 to 14 days. In sequential therapy group, 34 patients received intravenous cefotaxime sodium for 3 to 5 days, Seriously changed to cefixime particles oral treatment of 5 to 7 days. Results: The total effective rates of the control group and the sequential therapy group were respectively 86.11% and 82.35% (P> 0.05). The average cost was 1.7 ± 0.4 and 2.3 ± 0.7 respectively (P <0.05). Conclusions: Sequential therapy is safe and effective in children with community-acquired pneumonia and has good compliance and low cost.